Researchers have identified other compounds in wheat, specifically, that they say could be responsible: fructans and amylase trypsin inhibitors. What's more, the results of one study suggest that ...
ARCT-810 is under clinical development by Arcturus Therapeutics and currently in Phase I for Ornithine-Transcarbamylase Deficiency. According to GlobalData, Phase I drugs for ...
College of Life Science, Anhui Agricultural University, No. 130, Changjiang Road, Hefei 230036, Anhui, People’s Republic of China ...